Vanda Pharmaceuticals Inc. VNDA
- HETLIOZ — Non-24-Hour Sleep-Wake Disorder Preclinical
- HETLIOZ — Smith-Magenis Syndrome Approved
- HETLIOZ — Jet Lag Disorder NDA Submitted
- HETLIOZ — Insomnia NDA Submitted
- HETLIOZ — Delayed Sleep Phase Disorder Phase 3
MT1 (1 companies · 5 programs)
Companies with an active program directed at MT1.